Final decisions on various projects will be made by the Mississippi Legislature in the upcoming session, as the state’s Opioid Settlement Council finalized a list of initiatives this week. Lawmakers will ultimately grant final approval during the legislative process.

Funding from Opioid Settlement

Over the next 15 years, Mississippi is set to receive hundreds of millions of dollars from a settlement with pharmaceutical companies accused of profiting from the opioid crisis. This funding aims to address the increasing rates of addiction and overdose among Mississippi citizens.

Project Recommendation Process

The council’s recommendations involved reassessing certain projects based on application issues or categorizing them as non-abatement projects, meaning they do not comply with the stricter criteria mandatory for opioid treatment initiatives. The non-abatement category is expected to draw from approximately $14 million, representing about 15 percent of the total funding.

Most significant adjustments occurred within the top funding tiers, particularly tiers one and two, which are most likely to receive funding before the initial year’s allocation is exhausted. The opioid settlement funds will be allocated across multiple years to support projects aimed at addressing opioid misuse and enhancing treatment options.

Key Project Amendments

One notable change involved a proposal from Essential Touchstone, which requested $1.15 million to provide trauma-informed care aimed at reducing opioid-related hospitalizations. Chief Justice Michael Randolph moved the application down to tier three due to concerns over financial transparency and the qualifications of the organization.

Another application from Jacob’s Well was amended following concerns that their program barred participants from accessing prescribed medications. Council member Mark Stovall emphasized the need for careful language to not prohibit necessary medical treatments.

Novel Approaches from Stercus Bioanalytics

Additionally, Stercus Bioanalytics submitted a request for $8.8 million to analyze opioid consumption patterns in Mississippi through wastewater sampling technology. This data could illuminate the prevalence of opioid use in various public facilities. While an initial amendment to protect private residences from sampling was suggested, it was ultimately withdrawn.

State Health Officer Dr. Daniel Edney confirmed that while this technology is beneficial for some health monitoring, its efficacy in addiction abatement remains under scrutiny.

Council’s Future Directions

As the Council wrapped up its current year’s review, member James Moore expressed concerns regarding the potential for conflicts of interest among council members in the grading of nearly 100 submitted projects. He proposed using external groups for a fairer assessment of future submissions.

This year marks the commencement of the Council’s ongoing efforts to identify and recommend projects funded by the opioid settlement, signifying an evolving landscape in Mississippi’s approach to addressing the opioid crisis and related issues.

Author: MScannaBIZ

MScannaBIZ is here to make sure patients, businesses, and professionals never get left behind. We started in 2022 as a Mississippi cannabis news source, covering the legislation, the licenses, and the launches that shaped the state's emerging industry. As the Mississippi Medical Cannabis Program took shape, so did we, evolving into the state's most comprehensive cannabis platform. Today MScannaBIZ is Mississippi's premier destination for finding licensed dispensaries, booking certified cannabis doctors, discovering deals and events, and staying informed with the latest industry news. With over 300 businesses in our directory and new listings added daily, we're the most complete cannabis resource in the state. Our mission is simple make Mississippi's medical cannabis ecosystem accessible, transparent, and thriving for everyone in it.

Leave a Reply

Your email address will not be published. Required fields are marked *